Effect of a Unani treatment in urinary infection.
Not Applicable
Completed
- Conditions
- Health Condition 1: N390- Urinary tract infection, site notspecified
- Registration Number
- CTRI/2020/02/023404
- Lead Sponsor
- ational Institute of Unani Mediicne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women diagnosed with clinical features such as Pusht me Dard, Usr al-bawl(dysuria), Bawl al-Dam(haematuria), Salsal al-Bawl(urgency), Hurqa al-Bawl(Burning), Taqtir al-Bawl (dribbling).
Clinical features of uncomplicated urinary tract infection (uUTI) symptom as per UTI Assessment (UTISA) questionnaire.
Exclusion Criteria
Women aged up to 18 years and over 60 years.
Pregnant and lactating women
Those with complicated UTI such as associated with pyelonephritis, urolithiasis, diabetes, neurological conditions or urinary tract obstructions.
Women who will be catheterised.
Hypersensitivity to nitrofurantoin and impaired renal function
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in clinical features (urinary frequency, urgency, dysuria or haematuria) assessed by UTISA questionnaireTimepoint: after trial on 9th or 10th day
- Secondary Outcome Measures
Name Time Method Reduction in Severity (e.g., intensity of pain, urgency, frequency and burning) of uncomplicated UTI.6 <br/ ><br>2. Improvements in quality of life (as estimated by validated outcomes measures SF-12). <br/ ><br>3. Morisky Medication Adherence Scale-4 used to assess compliance with herbal medicine. <br/ ><br> <br/ ><br>Timepoint: After trial on 9th or 10 th day